Although there was no detectable change in platelet COX/LOX ratio one month after the STZ-induced development of diabetes, treatment with PRE-084 or (S)-L1 significantly reduced it compared to the vehicle-treated, diabetic samples. This evidence concerns the gene LOX and diabetes mellitus.